<DOC>
	<DOCNO>NCT00384436</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy escitalopram active comparator severely depress patient</brief_summary>
	<brief_title>Fixed Dose Comparison Escitalopram Active Comparator Severely Depressed Patients</brief_title>
	<detailed_description>Escitalopram S-enantiomer citalopram . Both escitalopram citalopram selective serotonin reuptake inhibitor ( SSRIs ) use treat depression adult . This study design evaluate safety efficacy escitalopram active comparator severely depressed patient .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients must meet DSMIV criterion Major Depressive Disorder . Patients must severe depression . MADRS great equal 30 Women pregnant , woman breastfeed study , woman childbearing potential practicing reliable method birth control . Patients consider suicide risk . Patients currently meet DSMIV criterion : principal diagnosis Axis I disorder MDD ( comorbid GAD allow ) , bipolar disorder , schizophrenia psychotic disorder , obsessivecompulsive disorder , dysthymia . Patients family history bipolar disorder , schizophrenia , psychotic disorder . Patients history psychotic disorder psychotic feature .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Major Depressive Disorder</keyword>
</DOC>